Loading...
Header Logo
Keywords
Last Name
KP Region

Lisa J Herrinton PhD

TitleResearch Scientist III
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
ORCID ORCID Icon0000-0002-5702-7162 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Lisa Herrinton, PhD, is a senior research scientist and epidemiologist at the Kaiser Permanente Northern California Division of Research. She is a standing member of the Healthcare Outcomes and Effectiveness study section at the Agency for Healthcare Research and Quality (AHRQ) and has served on study section for the Centers for Disease Control, National Eye Institute, National Cancer Institute, and other federal agencies. Dr. Herrinton has 20 years of experience using a diverse range of research methods to investigate important questions in public health and health services. Most recently, she is conducing a program in implementation research, working with Kaiser Permanente physicians and health plan leaders to identify high priority topics suitable for integrating care delivery, quality improvement, and research. In addition, Dr. Herrinton is focused on using innovative approaches to realizing value from Kaiser Permanente's electronic medical record. These efforts cover diverse clinical areas including cataract surgery, oncology, and registry building across medical and surgical specialties. Earlier, she elucidated risk factors in the development of breast, ovarian, lung, and colorectal cancer, as well as lymphoma. In autoimmune disease, she built registries in inflammatory bowel disease, rheumatology, and psoriasis. Dr. Herrinton received her doctoral training at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington, and her master's training at Harvard University. She has published more than 160 peer-reviewed publications and several book chapters. In addition, she has led numerous collaborative activities and mentored many scientists and physician-investigators. Before her training in epidemiology, she was an environmental health manager. She also served as a high school science and math teacher through the Peace Corps in Swaziland, Africa. Besides her work, Dr. Herrinton enjoys her family and friends, hiking, biking, and swimming.

    Collapse Research 
    Collapse research activities and funding
    K07CA070969     (HERRINTON, LISA J)May 1, 1996 - Apr 30, 2001
    NIH/NCI
    PREVENTIVE ONCOLOGY ACADEMIC AWARDS
    Role: Principal Investigator

    R03CA099261     (HERRINTON, LISA J)Sep 30, 2002 - Aug 31, 2004
    NIH/NCI
    Epidemiology of Marginal Zone Lymphoma
    Role: Principal Investigator

    R01CA106912     (KROUSE, ROBERT SCOTT)Sep 15, 2004 - Feb 28, 2015
    NIH/NCI
    HR-QOL in Colorectal Cancer Survivors with Stomas
    Role: Co-Principal Investigator

    RC1AI086107     (HERRINTON, LISA J.)Sep 28, 2009 - Aug 31, 2012
    NIH/NIAID
    Kaiser Permanente Autoimmune Disease Registry
    Role: Principal Investigator

    R21EY022989     (HERRINTON, LISA J.)Feb 1, 2013 - Jan 31, 2015
    NIH/NEI
    Comparative Effectiveness of Prophylaxis in Cataract Surgery
    Role: Principal Investigator

    R01HS021589     (HERRINTON, LISA J.)Sep 1, 2013 - Aug 31, 2015
    AHRQ
    Psoriasis treatments, cardiovascular disease, and diabetes
    Role: Principal Investigator

    R01EY027329     (HERRINTON, LISA J)Mar 1, 2017 - Feb 28, 2019
    NIH/NEI
    Predicting final visual acuity following cataract surgery
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lieu TA, Herrinton LJ, Buzkov DE, Liu L, Lyons D, Neugebauer R, Needham T, Ng D, Prausnitz S, Stewart K, Van Den Eeden SK, Baer DM. Developing a Prognostic Information System for Personalized Care in Real Time. EGEMS (Wash DC). 2019 Mar 25; 7(1):2. PMID: 30937324.
      View in: PubMed
    2. Chong AJ, Fevrier HB, Herrinton LJ. Long-term follow-up of pediatric open and laparoscopic inguinal hernia repair. J Pediatr Surg. 2019 Feb 27. PMID: 30885559.
      View in: PubMed
    3. Liu LH, Fevrier HB, Goldfien R, Hemmerling A, Herrinton LJ. Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus. J Rheumatol. 2019 Feb 01. PMID: 30709949.
      View in: PubMed
    4. Marwaha S, Fevrier HB, Alexeeff SE, Crowley E, Haiman M, Pham N, Tuerk MJ, Wukda D, Hartmann M, Herrinton LJ. Comparative Effectiveness Study of Face-to-Face and Teledermatology Workflows for Diagnosing Skin Cancer. J Am Acad Dermatol. 2019 Feb 01. PMID: 30738843.
      View in: PubMed
    5. Liu L, Herrinton LJ, Alexeeff S, Karter AJ, Amsden LB, Carolan J, Shorstein NH. Visual outcomes after cataract surgery in patients with type 2 diabetes. J Cataract Refract Surg. 2019 Apr; 45(4):404-413. PMID: 30638823.
      View in: PubMed
    6. Sun V, Wendel CS, Demark-Wahnefried W, Grant M, McMullen CK, Bulkley JE, Herrinton LJ, Hornbrook MC, Krouse RS. Diet and Behavior Modifications by Long-term Rectal Cancer Survivors to Manage Bowel Dysfunction-Associated Symptoms. Nutr Cancer. 2019; 71(1):89-99. PMID: 30572723.
      View in: PubMed
    7. Herrinton LJ, Ray GT, Wu JJ, Fireman B, Liu L, Goldfien R, Curtis JR. Anti-TNF and Physiologic Measures of Metabolic Disease in Rheumatoid Arthritis. J Clin Rheumatol. 2018 Nov 07. PMID: 30418345.
      View in: PubMed
    8. Suh-Burgmann E, Flanagan T, Osinski T, Alavi M, Herrinton L. Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System. Obstet Gynecol. 2018 Nov; 132(5):1101-1111. PMID: 30303910.
      View in: PubMed
    9. Ge IY, Fevrier HB, Conell C, Kheraj MN, Flint AC, Smith DS, Herrinton LJ. Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection. Ther Adv Urol. 2018 Oct; 10(10):283-293. PMID: 30186366.
      View in: PubMed
    10. Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):872-877. PMID: 29932281.
      View in: PubMed
    11. Suh-Burgmann EJ, Flanagan T, Lee N, Osinski T, Sweet C, Lynch M, Caponigro M, Mehta J, Alavi M, Herrinton LJ. Large-Scale Implementation of Structured Reporting of Adnexal Masses on Ultrasound. J Am Coll Radiol. 2018 May; 15(5):755-761. PMID: 29571644.
      View in: PubMed
    12. Amsden LB, Davidson PT, Fevrier HB, Goldfien R, Herrinton LJ. Improving the quality of care and patient experience of care during the diagnosis of lupus: a qualitative study of primary care. Lupus. 2018 Jun; 27(7):1088-1099. PMID: 29546773.
      View in: PubMed
    13. Hornbrook MC, Grant M, Wendel C, Bulkley JE, Mcmullen CK, Altschuler A, Temple LK, Herrinton LJ, Krouse RS. Rectal Cancer Survivors' Participation in Productive Activities. Perm J. 2018; 22:17-022. PMID: 29236653.
      View in: PubMed
    14. Pan M, Alavi M, Herrinton LJ. Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. Perm J. 2018; 22:17-149. PMID: 29616914.
      View in: PubMed
    15. Herrinton LJ, Ray GT, Curtis JR, Wu JJ, Fireman B, Liu L, Goldfien R. An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches. Perm J. 2018; 22:17-101. PMID: 30010538.
      View in: PubMed
    16. Amsden LB, Shorstein NH, Fevrier H, Liu L, Carolan J, Herrinton LJ. Immediate sequential bilateral cataract surgery: surgeon preferences and concerns. Can J Ophthalmol. 2018 08; 53(4):337-341. PMID: 30119786.
      View in: PubMed
    17. Alavi M, Wendel CS, Krouse RS, Temple L, Hornbrook MC, Bulkley JE, McMullen CK, Grant M, Herrinton LJ. Erratum to: Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis. Ann Surg Oncol. 2017 12; 24(Suppl 3):694. PMID: 28815447.
      View in: PubMed
    18. Dall'Era M, Cisternas MG, Snipes K, Herrinton LJ, Gordon C, Helmick CG. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol. 2017 10; 69(10):1996-2005. PMID: 28891237.
      View in: PubMed
    19. Alavi M, Wendel CS, Krouse RS, Temple L, Hornbrook MC, Bulkley JE, McMullen CK, Grant M, Herrinton LJ. Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis. Ann Surg Oncol. 2017 Nov; 24(12):3596-3603. PMID: 28785900.
      View in: PubMed
    20. Krouse RS, Wendel CS, Garcia DO, Grant M, Temple LKF, Going SB, Hornbrook MC, Bulkley JE, McMullen CK, Herrinton LJ. Physical activity, bowel function, and quality of life among rectal cancer survivors. Qual Life Res. 2017 11; 26(11):3131-3142. PMID: 28677077.
      View in: PubMed
    21. Herrinton LJ, Liu L, Alexeeff S, Carolan J, Shorstein NH. Immediate Sequential vs. Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes. Ophthalmology. 2017 08; 124(8):1126-1135. PMID: 28438415.
      View in: PubMed
    22. Shorstein NH, Lucido C, Carolan J, Liu L, Slean G, Herrinton LJ. Failure Modes and Effects Analysis of bilateral same-day cataract surgery. J Cataract Refract Surg. 2017 Mar; 43(3):318-323. PMID: 28410711.
      View in: PubMed
    23. Slean GR, Shorstein NH, Liu L, Paschal JF, Winthrop KL, Herrinton LJ. Pathogens and antibiotic sensitivities in endophthalmitis. Clin Exp Ophthalmol. 2017 Jul; 45(5):481-488. PMID: 28013528.
      View in: PubMed
    24. Liu L, Shorstein NH, Amsden LB, Herrinton LJ. Natural language processing to ascertain two key variables from operative reports in ophthalmology. Pharmacoepidemiol Drug Saf. 2017 Apr; 26(4):378-385. PMID: 28052483.
      View in: PubMed
    25. Mcmullen C, Liu L, Bulkley JE, Hornbrook MC, Wendel C, Grant M, Altschuler A, Temple LK, Krouse RS, Herrinton L. Participation in Activities Associated With Quality of Life for Long-Term Survivors of Rectal Cancer. Perm J. 2017; 21:16-011. PMID: 28241904.
      View in: PubMed
    26. Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA. Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. J Comp Eff Res. 2017 Jan; 6(1):25-32. PMID: 27935320.
      View in: PubMed
    27. Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE, Newberry RD, Osuntokun BO, Patel AS, Saeed SA, Targan SR, Valentine JF, Wang MH, Zonca M, Rioux JD, Duerr RH, Silverberg MS, Cho JH, Hakonarson H, Zwick ME, McGovern DP, Kugathasan S. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. 2017 01; 152(1):206-217.e2. PMID: 27693347.
      View in: PubMed
    28. Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Reply. Ophthalmology. 2016 09; 123(9):e55. PMID: 27549892.
      View in: PubMed
    29. Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, Wu JJ, Herrinton LJ. Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. Perm J. 2016; 20(4):15-151. PMID: 27479952.
      View in: PubMed
    30. Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Herrinton LJ, Hornbrook MC, Krouse RS. Sexual Function and Health-Related Quality of Life in Long-Term Rectal Cancer Survivors. J Sex Med. 2016 07; 13(7):1071-9. PMID: 27318020.
      View in: PubMed
    31. Herrinton LJ, Liu L, Goldfien R, Michaels MA, Tran TN. Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials. J Rheumatol. 2016 08; 43(8):1503-9. PMID: 27370880.
      View in: PubMed
    32. Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814. PMID: 27146273.
      View in: PubMed
    33. Navarro-Millán I, Herrinton LJ, Chen L, Harrold L, Liu L, Curtis JR. Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability. PLoS One. 2016; 11(3):e0149781. PMID: 27007811.
      View in: PubMed
    34. Herrinton LJ, Altschuler A, McMullen CK, Bulkley JE, Hornbrook MC, Sun V, Wendel CS, Grant M, Baldwin CM, Demark-Wahnefried W, Temple LK, Krouse RS. Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery. CA Cancer J Clin. 2016 09; 66(5):387-97. PMID: 26999757.
      View in: PubMed
    35. Herrinton LJ, Harrold L, Salman C, Liu L, Goldfien R, Asgari M, Gelfand JM, Wu JJ, Curtis JR. Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. Perm J. 2016; 20(1):4-12. PMID: 26694020.
      View in: PubMed
    36. Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL, Chang WJ, Melles RB, Fong DS. Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery. Ophthalmology. 2016 Feb; 123(2):287-94. PMID: 26459998.
      View in: PubMed
    37. Wong DC, Waxman MD, Herrinton LJ, Shorstein NH. Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery. JAMA Ophthalmol. 2015 Oct; 133(10):1194-7. PMID: 26226062.
      View in: PubMed
    38. Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery. Ophthalmology. 2015 Dec; 122(12):2450-6. PMID: 26409728.
      View in: PubMed
    39. Chongpison Y, Hornbrook MC, Harris RB, Herrinton LJ, Gerald JK, Grant M, Bulkley JE, Wendel CS, Krouse RS. Self-reported depression and perceived financial burden among long-term rectal cancer survivors. Psychooncology. 2016 11; 25(11):1350-1356. PMID: 26365584.
      View in: PubMed
    40. Shen L, Melles RB, Metlapally R, Barcellos L, Schaefer C, Risch N, Herrinton LJ, Wildsoet C, Jorgenson E. The Association of Refractive Error with Glaucoma in a Multiethnic Population. Ophthalmology. 2016 Jan; 123(1):92-101. PMID: 26260281.
      View in: PubMed
    41. Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Altschuler A, Ramirez M, Baldwin CM, Herrinton LJ, Hornbrook MC, Krouse RS. Dietary and Behavioral Adjustments to Manage Bowel Dysfunction After Surgery in Long-Term Colorectal Cancer Survivors. Ann Surg Oncol. 2015 Dec; 22(13):4317-24. PMID: 26159443.
      View in: PubMed
    42. Hutfless S, Abramson O, Heyman MB, Bayless TM, Li DK, Winthrop K, Herrinton LJ. Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis. Gastroenterol Res Pract. 2015; 2015:690581. PMID: 26074957.
      View in: PubMed
    43. Herrinton LJ, Liu L, Altschuler A, Dell R, Rabrenovich V, Compton-Phillips AL. Big data, miniregistries: a rapid-turnaround solution to get quality improvement data into the hands of medical specialists. Perm J. 2015; 19(2):15-21. PMID: 25785640.
      View in: PubMed
    44. Arterburn D, Powers JD, Toh S, Polsky S, Butler MG, Portz JD, Donahoo WT, Herrinton L, Williams RJ, Vijayadeva V, Fisher D, Bayliss EA. Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypass. JAMA Surg. 2014 Dec; 149(12):1279-87. PMID: 25353723.
      View in: PubMed
    45. Dublin S, Johnson KE, Walker RL, Avalos LA, Andrade SE, Beaton SJ, Davis RL, Herrinton LJ, Pawloski PA, Raebel MA, Smith DH, Toh S, Caughey AB. Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt). 2014 Nov; 23(11):904-11. PMID: 25330378.
      View in: PubMed
    46. Carnahan MC, Chang WJ, Shorstein NH, Herrinton LJ. New benchmark in preventing phacoemulsification-related endophthalmitis. J Cataract Refract Surg. 2014 Sep; 40(9):1568. PMID: 25135553.
      View in: PubMed
    47. Wendel CS, Grant M, Herrinton L, Temple LK, Hornbrook MC, McMullen CK, Bulkley JE, Altschuler A, Krouse RS. Reliability and validity of a survey to measure bowel function and quality of life in long-term rectal cancer survivors. Qual Life Res. 2014 Dec; 23(10):2831-40. PMID: 24890826.
      View in: PubMed
    48. Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin. 2014 Aug; 30(8):1687-99. PMID: 24635013.
      View in: PubMed
    49. Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014 Feb; 20(2):398-415. PMID: 24280882.
      View in: PubMed
    50. Sun V, Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Krouse RS. From diagnosis through survivorship: health-care experiences of colorectal cancer survivors with ostomies. Support Care Cancer. 2014 Jun; 22(6):1563-70. PMID: 24442998.
      View in: PubMed
    51. Daley MF, Newton DA, DeBar L, Newcomer SR, Pieper L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Nakasato C, Herrinton LJ, Bussing R. Accuracy of Electronic Health Record-Derived Data for the Identification of Incident ADHD. J Atten Disord. 2017 03; 21(5):416-425. PMID: 24510475.
      View in: PubMed
    52. Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ. Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol. 2014 Oct; 28(10):1380-7. PMID: 24708441.
      View in: PubMed
    53. Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci. 2014 Feb; 59(2):287-94. PMID: 24173809.
      View in: PubMed
    54. Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA. Cardiovascular risk in rheumatoid arthritis: comparing TNF-a blockade with nonbiologic DMARDs. Am J Med. 2013 Aug; 126(8):730.e9-730.e17. PMID: 23885678.
      View in: PubMed
    55. Baddley JW, Winthrop KL, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Ann Rheum Dis. 2014 Nov; 73(11):1942-8. PMID: 23852763.
      View in: PubMed
    56. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF, Stein CM, Griffin MR. Initiation of tumor necrosis factor a antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken). 2013 Jul; 65(7):1085-94. PMID: 23281339.
      View in: PubMed
    57. Toh S, Baker MA, Brown JS, Kornegay C, Platt R. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9. PMID: 23529063.
      View in: PubMed
    58. Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, Herrinton LJ. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):842-9. PMID: 23637091.
      View in: PubMed
    59. Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol. 2013 Jul; 40(7):1218-25. PMID: 23588938.
      View in: PubMed
    60. Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski PA, Raebel MA, Roblin D, Brown JS. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):517-23. PMID: 23512870.
      View in: PubMed
    61. Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R. Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics. 2013 Mar 14; 5(1):179-200. PMID: 24300404.
      View in: PubMed
    62. Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA. 2013 Mar 06; 309(9):887-95. PMID: 23462785.
      View in: PubMed
    63. Avery TR, Kulldorff M, Vilk Y, Li L, Cheetham TC, Dublin S, Davis RL, Liu L, Herrinton L, Brown JS. Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):488-95. PMID: 23401239.
      View in: PubMed
    64. Shorstein N, Winthrop K, Herrinton L. Reply: Intracameral antibiotics and endophthalmitis incidence. J Cataract Refract Surg. 2013 Feb; 39(2):313. PMID: 23332286.
      View in: PubMed
    65. Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL, Solomon DH, Curtis JR, Lewis JD, Saag KG. Association between anti-TNF-a therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf. 2013 Apr; 22(4):394-402. PMID: 23359391.
      View in: PubMed
    66. Herrinton LJ. Regarding: a tale of two cohorts. Gastroenterology. 2013 Mar; 144(3):e21-2. PMID: 23357065.
      View in: PubMed
    67. Sun V, Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Baldwin CM, Krouse RS. Surviving colorectal cancer: long-term, persistent ostomy-specific concerns and adaptations. J Wound Ostomy Continence Nurs. 2013 Jan-Feb; 40(1):61-72. PMID: 23222968.
      View in: PubMed
    68. Haynes K, Beukelman T, Curtis JR, Newcomb C, Herrinton LJ, Graham DJ, Solomon DH, Griffin MR, Chen L, Liu L, Saag KG, Lewis JD. Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum. 2013 Jan; 65(1):48-58. PMID: 23055441.
      View in: PubMed
    69. Kawatkar AA, Jacobsen SJ, Levy GD, Medhekar SS, Venkatasubramaniam KV, Herrinton LJ. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1649-56. PMID: 22674912.
      View in: PubMed
    70. Skeps R, McMullen CK, Wendel CS, Bulkley J, Grant M, Mohler J, Hornbrook MC, Krouse RS, Herrinton LJ. Changes in body mass index and stoma related problems in the elderly. J Geriatr Oncol. 2013 Jan; 4(1):84-9. PMID: 24071496.
      View in: PubMed
    71. Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, Griffin MR, Solomon DH, Saag KG, Lewis JD. Association between anti-TNF-a therapy and all-cause mortality. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1311-20. PMID: 23065964.
      View in: PubMed
    72. Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013 Jan; 39(1):8-14. PMID: 23036356.
      View in: PubMed
    73. Grant M, McMullen CK, Altschuler A, Hornbrook MC, Herrinton LJ, Wendel CS, Baldwin CM, Krouse RS. Irrigation practices in long-term survivors of colorectal cancer with colostomies. Clin J Oncol Nurs. 2012 Oct; 16(5):514-9. PMID: 23022935.
      View in: PubMed
    74. Winthrop KL, Chen L, Fraunfelder FW, Ku JH, Varley CD, Suhler E, Hills WL, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton LJ, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR. Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol. 2013 Jan; 155(1):183-189.e1. PMID: 22967869.
      View in: PubMed
    75. Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012 Nov; 67(5):924-30. PMID: 22664308.
      View in: PubMed
    76. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9. PMID: 22609382.
      View in: PubMed
    77. Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, McFarland B, Austin D, Radcliffe L, Suhler E, Choi D, Rosenbaum JT, Herrinton LJ. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2013 Jan; 72(1):37-42. PMID: 22523429.
      View in: PubMed
    78. Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ. Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. Dig Dis Sci. 2012 Aug; 57(8):2149-56. PMID: 22447434.
      View in: PubMed
    79. Toh S, Li L, Harrold LR, Bayliss EA, Curtis JR, Liu L, Chen L, Grijalva CG, Herrinton LJ. Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics? Pharmacoepidemiol Drug Saf. 2012 May; 21(5):524-34. PMID: 22411435.
      View in: PubMed
    80. Forrow S, Campion DM, Herrinton LJ, Nair VP, Robb MA, Wilson M, Platt R. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:12-7. PMID: 22262588.
      View in: PubMed
    81. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR. Initiation of tumor necrosis factor-a antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA. 2011 Dec 07; 306(21):2331-9. PMID: 22056398.
      View in: PubMed
    82. Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011 Dec; 106(12):2146-53. PMID: 22031357.
      View in: PubMed
    83. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchel EF, Stein CM, Griffin MR. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1415-24. PMID: 22121511.
      View in: PubMed
    84. Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf. 2011 Nov; 20(11):1199-209. PMID: 21919113.
      View in: PubMed
    85. Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Wendel CS, Baldwin CM, Krouse RS. Gender differences in quality of life among long-term colorectal cancer survivors with ostomies. Oncol Nurs Forum. 2011 Sep; 38(5):587-96. PMID: 21875846.
      View in: PubMed
    86. Herrinton LJ, Liu L, Abramson O, Jaffe ES. The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. Pharmacoepidemiol Drug Saf. 2012 Jan; 21(1):49-52. PMID: 21823196.
      View in: PubMed
    87. Hornbrook MC, Wendel CS, Coons SJ, Grant M, Herrinton LJ, Mohler MJ, Baldwin CM, McMullen CK, Green SB, Altschuler A, Rawl SM, Krouse RS. Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores. Med Care. 2011 Mar; 49(3):321-6. PMID: 21224741.
      View in: PubMed
    88. Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):229-35. PMID: 21351303.
      View in: PubMed
    89. Li DK, Zhou Z, Miao M, He Y, Wang J, Ferber J, Herrinton LJ, Gao E, Yuan W. Urine bisphenol-A (BPA) level in relation to semen quality. Fertil Steril. 2011 Feb; 95(2):625-30.e1-4. PMID: 21035116.
      View in: PubMed
    90. Velayos FS, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Abramson O, Perry GS, Herrinton LJ. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology. 2010 Nov; 139(5):1511-8. PMID: 20659470.
      View in: PubMed
    91. Rassen JA, Solomon DH, Curtis JR, Herrinton L, Schneeweiss S. Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics. Med Care. 2010 Jun; 48(6 Suppl):S83-9. PMID: 20473213.
      View in: PubMed
    92. Li DK, Zhou Z, Miao M, He Y, Qing D, Wu T, Wang J, Weng X, Ferber J, Herrinton LJ, Zhu Q, Gao E, Yuan W. Relationship between urine bisphenol-A level and declining male sexual function. J Androl. 2010 Sep-Oct; 31(5):500-6. PMID: 20467048.
      View in: PubMed
    93. Abramson O, Durant M, Mow W, Finley A, Kodali P, Wong A, Tavares V, McCroskey E, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Perry GS, Cannon R, Herrinton LJ. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr. 2010 Aug; 157(2):233-239.e1. PMID: 20400099.
      View in: PubMed
    94. Liu L, Herrinton LJ, Hornbrook MC, Wendel CS, Grant M, Krouse RS. Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis. Dis Colon Rectum. 2010 Feb; 53(2):200-12. PMID: 20087096.
      View in: PubMed
    95. Li D, Zhou Z, Qing D, He Y, Wu T, Miao M, Wang J, Weng X, Ferber JR, Herrinton LJ, Zhu Q, Gao E, Checkoway H, Yuan W. Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod. 2010 Feb; 25(2):519-27. PMID: 19906654.
      View in: PubMed
    96. Liu L, Allison JE, Herrinton LJ. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf. 2009 Nov; 18(11):1086-93. PMID: 19672855.
      View in: PubMed
    97. Krouse RS, Herrinton LJ, Grant M, Wendel CS, Green SB, Mohler MJ, Baldwin CM, McMullen CK, Rawl SM, Matayoshi E, Coons SJ, Hornbrook MC. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol. 2009 Oct 01; 27(28):4664-70. PMID: 19720920.
      View in: PubMed
    98. Baldwin CM, Grant M, Wendel C, Hornbrook MC, Herrinton LJ, McMullen C, Krouse RS. Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies. J Clin Sleep Med. 2009 Aug 15; 5(4):335-43. PMID: 19968011.
      View in: PubMed
    99. Lewis JD, Abramson O, Pascua M, Liu L, Asakura LM, Velayos FS, Hutfless SM, Alison JE, Herrinton LJ. Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations. Clin Gastroenterol Hepatol. 2009 Nov; 7(11):1195-201; quiz 1141-2. PMID: 19631285.
      View in: PubMed
    100. Mazor KM, Sabin JE, Goff SL, Smith DH, Rolnick S, Roblin D, Raebel MA, Herrinton LJ, Gurwitz JH, Boudreau D, Meterko V, Dodd KS, Platt R. Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):554-61. PMID: 19402030.
      View in: PubMed
    101. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology. 2009 Aug; 137(2):502-11. PMID: 19445944.
      View in: PubMed
    102. He Y, Miao M, Herrinton LJ, Wu C, Yuan W, Zhou Z, Li DK. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res. 2009 Jul; 109(5):629-33. PMID: 19426969.
      View in: PubMed
    103. Altschuler A, Ramirez M, Grant M, Wendel C, Hornbrook MC, Herrinton L, Krouse RS. The influence of husbands' or male partners' support on women's psychosocial adjustment to having an ostomy resulting from colorectal cancer. J Wound Ostomy Continence Nurs. 2009 May-Jun; 36(3):299-305. PMID: 19448512.
      View in: PubMed
    104. Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34. PMID: 19148879.
      View in: PubMed
    105. Lundy JJ, Coons SJ, Wendel C, Hornbrook MC, Herrinton L, Grant M, Krouse RS. Exploring household income as a predictor of psychological well-being among long-term colorectal cancer survivors. Qual Life Res. 2009 Mar; 18(2):157-61. PMID: 19132550.
      View in: PubMed
    106. Walsh KE, Dodd KS, Seetharaman K, Roblin DW, Herrinton LJ, Von Worley A, Usmani GN, Baer D, Gurwitz JH. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009 Feb 20; 27(6):891-6. PMID: 19114695.
      View in: PubMed
    107. Allison J, Herrinton LJ, Liu L, Yu J, Lowder J. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008 Sep; 6(9):999-1003. PMID: 18774533.
      View in: PubMed
    108. Pressman AR, Hutfless S, Velayos F, Fireman B, Lewis JD, Allison J, Abramson O, Herrinton LJ. Patterns of infliximab use among Crohn's disease patients in a community setting. Inflamm Bowel Dis. 2008 Sep; 14(9):1265-72. PMID: 18452199.
      View in: PubMed
    109. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol. 2008 Aug; 103(8):1998-2006. PMID: 18796097.
      View in: PubMed
    110. Altschuler A, Collins B, Lewis JD, Velayos F, Allison JE, Hutfless S, Liu L, Herrinton LJ. Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008 Jul; 14(7):992-9. PMID: 18300277.
      View in: PubMed
    111. Hutfless S, Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008 Sep 01; 28(5):598-605. PMID: 18549465.
      View in: PubMed
    112. Mohler MJ, Coons SJ, Hornbrook MC, Herrinton LJ, Wendel CS, Grant M, Krouse RS. The health-related quality of life in long-term colorectal cancer survivors study: objectives, methods and patient sample. Curr Med Res Opin. 2008 Jul; 24(7):2059-70. PMID: 18544186.
      View in: PubMed
    113. Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599. PMID: 18398101.
      View in: PubMed
    114. Herrinton LJ, Liu L, Shoor S, Mines D. Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Ann Rheum Dis. 2008 Apr; 67(4):574-5. PMID: 18349167.
      View in: PubMed
    115. Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL, Fletcher SW, Emmons KM, Geiger AM. Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008 Jan-Feb; 14(1):25-32. PMID: 18186862.
      View in: PubMed
    116. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84. PMID: 17955500.
      View in: PubMed
    117. Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 Oct; 45(10 Supl 2):S29-37. PMID: 17909379.
      View in: PubMed
    118. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology. 2007 Dec; 133(6):1779-86. PMID: 18054550.
      View in: PubMed
    119. Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007 Sep; 45(9):869-75. PMID: 17712257.
      View in: PubMed
    120. Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA, Jackson JM, Coughlin SS. Complications at the end of life in ovarian cancer. J Pain Symptom Manage. 2007 Sep; 34(3):237-43. PMID: 17606360.
      View in: PubMed
    121. Rolnick SJ, Altschuler A, Nekhlyudov L, Elmore JG, Greene SM, Harris EL, Herrinton LJ, Barton MB, Geiger AM, Fletcher SW. What women wish they knew before prophylactic mastectomy. Cancer Nurs. 2007 Jul-Aug; 30(4):285-91; quiz 292-3. PMID: 17666977.
      View in: PubMed
    122. Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol. 2007 Jul; 102(7):1429-35. PMID: 17437504.
      View in: PubMed
    123. Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ, Chan KA, Platt R, Hiatt D, O'Connor S. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007 Apr; 13(4):451-61. PMID: 17219403.
      View in: PubMed
    124. Aiello EJ, Buist DS, Wagner EH, Tuzzio L, Greene SM, Lamerato LE, Field TS, Herrinton LJ, Haque R, Hart G, Bischoff KJ, Geiger AM. Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat. 2008 Feb; 107(3):397-403. PMID: 17393300.
      View in: PubMed
    125. Fenton JJ, Rolnick SJ, Harris EL, Barton MB, Barlow WE, Reisch LM, Herrinton LJ, Geiger AM, Fletcher SW, Elmore JG. Specificity of clinical breast examination in community practice. J Gen Intern Med. 2007 Mar; 22(3):332-7. PMID: 17356964.
      View in: PubMed
    126. Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, Herrinton L, Quinn VP, Hart G, Hornbrook MC, Gurwitz JH, Wagner EH. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007 Feb 01; 109(3):612-20. PMID: 17186529.
      View in: PubMed
    127. Rolnick SJ, Jackson J, Nelson WW, Butani A, Herrinton LJ, Hornbrook M, Neslund-Dudas C, Bachman DJ, Coughlin SS. Pain management in the last six months of life among women who died of ovarian cancer. J Pain Symptom Manage. 2007 Jan; 33(1):24-31. PMID: 17196904.
      View in: PubMed
    128. Jackson JM, Rolnick SJ, Coughlin SS, Neslund-Dudas C, Hornbrook MC, Darbinian J, Bachman DJ, Herrinton LJ. Social support among women who died of ovarian cancer. Support Care Cancer. 2007 May; 15(5):547-56. PMID: 17177041.
      View in: PubMed
    129. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50. PMID: 17114650.
      View in: PubMed
    130. Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM. Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol. 2007 Feb; 14(2):686-94. PMID: 17103066.
      View in: PubMed
    131. Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ. Variations in hospice use among cancer patients. J Natl Cancer Inst. 2006 Aug 02; 98(15):1053-9. PMID: 16882942.
      View in: PubMed
    132. Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006 Mar 20; 24(9):1350-6. PMID: 16549829.
      View in: PubMed
    133. Iribarren C, Herrinton LJ, Darbinian JA, Tamarkin L, Malinowski D, Vogelman JH, Orentreich N, Baer D. Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race? Vasc Med. 2006 Feb; 11(1):13-20. PMID: 16669408.
      View in: PubMed
    134. Elmore JG, Reisch LM, Barton MB, Barlow WE, Rolnick S, Harris EL, Herrinton LJ, Geiger AM, Beverly RK, Hart G, Yu O, Greene SM, Weiss NS, Fletcher SW. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005 Jul 20; 97(14):1035-43. PMID: 16030301.
      View in: PubMed
    135. Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005 Jul 01; 23(19):4275-86. PMID: 15795415.
      View in: PubMed
    136. Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med. 2005 Mar 14; 165(5):516-20. PMID: 15767526.
      View in: PubMed
    137. Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005; (35):3-11. PMID: 16287880.
      View in: PubMed
    138. Nekhlyudov L, Bower M, Herrinton LJ, Altschuler A, Greene SM, Rolnick S, Elmore JG, Harris EL, Liu A, Emmons KM, Fletcher SW, Geiger AM. Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005; (35):55-60. PMID: 16287886.
      View in: PubMed
    139. Barton MB, West CN, Liu IL, Harris EL, Rolnick SJ, Elmore JG, Herrinton LJ, Greene SM, Nekhlyudov L, Fletcher SW, Geiger AM. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005; (35):61-6. PMID: 16287887.
      View in: PubMed
    140. Fenton JJ, Barton MB, Geiger AM, Herrinton LJ, Rolnick SJ, Harris EL, Barlow WE, Reisch LM, Fletcher SW, Elmore JG. Screening clinical breast examination: how often does it miss lethal breast cancer? J Natl Cancer Inst Monogr. 2005; (35):67-71. PMID: 16287888.
      View in: PubMed
    141. West CN, Geiger AM, Greene SM, Harris EL, Liu IL, Barton MB, Elmore JG, Rolnick S, Nekhlyudov L, Altschuler A, Herrinton LJ, Fletcher SW, Emmons KM. Race and ethnicity: comparing medical records to self-reports. J Natl Cancer Inst Monogr. 2005; (35):72-4. PMID: 16287889.
      View in: PubMed
    142. Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005; (35):88-95. PMID: 16287892.
      View in: PubMed
    143. Rolnick SJ, Hart G, Barton MB, Herrinton L, Flores SK, Paulsen KJ, Husson G, Harris EL, Geiger AM, Elmore JG, Fletcher SW. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data. Am J Manag Care. 2004 Apr; 10(4):257-62. PMID: 15124502.
      View in: PubMed
    144. Field TS, Cernieux J, Buist D, Geiger A, Lamerato L, Hart G, Bachman D, Krajenta R, Greene S, Hornbrook MC, Ansell G, Herrinton L, Reed G. Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. J Natl Cancer Inst. 2004 Jan 21; 96(2):148-52. PMID: 14734705.
      View in: PubMed
    145. Husson G, Herrinton LJ, Brox WT, Finkle W, Bernstein A, Shoor S, Greenland S. A cohort study of systemic and local complications of toe prostheses. Am J Orthop (Belle Mead NJ). 2003 Dec; 32(12):585-92. PMID: 14713064.
      View in: PubMed
    146. Husson G, Herrinton LJ. Regarding "a case-control study of sexually transmitted disease and risk of testicular cancer". Ann Epidemiol. 2003 Aug; 13(7):541-2. PMID: 12932631.
      View in: PubMed
    147. Geiger AM, Greene SM, Pardee RE, Hart G, Herrinton LJ, Macedo AM, Rolnick S, Harris EL, Barton MB, Elmore JG, Fletcher SW. A computerized system to facilitate medical record abstraction in cancer research (United States). Cancer Causes Control. 2003 Jun; 14(5):469-76. PMID: 12946042.
      View in: PubMed
    148. Herrinton LJ, Zhao W, Husson G. Management of cryptorchism and risk of testicular cancer. Am J Epidemiol. 2003 Apr 01; 157(7):602-5. PMID: 12672679.
      View in: PubMed
    149. Reisch LM, Fosse JS, Beverly K, Yu O, Barlow WE, Harris EL, Rolnick S, Barton MB, Geiger AM, Herrinton LJ, Greene SM, Fletcher SW, Elmore JG. Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol. 2003 Mar 15; 157(6):546-51. PMID: 12631545.
      View in: PubMed
    150. Herrinton LJ, Brox T, Greenland S, Finkle WD, Cattolica E, Shoor S. Regarding: a cohort study of systemic and local complications following implantation of testicular prostheses. Ann Epidemiol. 2003 Jan; 13(1):73-7. PMID: 12547488.
      View in: PubMed
    151. McGuire V, Herrinton L, Whittemore AS. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology. 2002 Mar; 13(2):231-4. PMID: 11880767.
      View in: PubMed
    152. Herrinton LJ, Voigt LF, Weiss NS, Beresford SA, Wingo PA. Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol. 2001 Nov; 11(8):529-33. PMID: 11709271.
      View in: PubMed
    153. Herrinton LJ, Husson G. Relation of childhood height and later risk of breast cancer. Am J Epidemiol. 2001 Oct 01; 154(7):618-23. PMID: 11581095.
      View in: PubMed
    154. Husson G, Herrinton LJ. How accurately does the medical record capture maternal history of cancer? Cancer Epidemiol Biomarkers Prev. 2000 Jul; 9(7):765-8. PMID: 10919750.
      View in: PubMed
    155. Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):25-8. PMID: 9456239.
      View in: PubMed
    156. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev. 1998; 20(2):187-203. PMID: 9919438.
      View in: PubMed
    157. Herrinton LJ, Friedman GD. Methylergonovine maleate and risk of breast cancer. Ann Epidemiol. 1997 Aug; 7(6):427-9. PMID: 9279452.
      View in: PubMed
    158. Herrinton LJ, Lemaitre RN, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR, Weiss NS. Lactose metabolism and time to pregnancy. Fertil Steril. 1996 Sep; 66(3):384-8. PMID: 8751734.
      View in: PubMed
    159. Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996 Mar; 7(2):224-30. PMID: 8740735.
      View in: PubMed
    160. Herrinton LJ. The epidemiology of monoclonal gammopathy of unknown significance: a review. Curr Top Microbiol Immunol. 1996; 210:389-95. PMID: 8565582.
      View in: PubMed
    161. Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995 Nov 01; 142(9):961-4. PMID: 7572977.
      View in: PubMed
    162. Herrinton LJ, Friedman GD, Baer D, Selby JV. Transferrin saturation and risk of cancer. Am J Epidemiol. 1995 Oct 01; 142(7):692-8. PMID: 7572938.
      View in: PubMed
    163. Herrinton LJ, Weiss NS, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol. 1995 Mar 01; 141(5):407-16. PMID: 7879785.
      View in: PubMed
    164. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology. 1995 Mar; 6(2):181-3. PMID: 7742407.
      View in: PubMed
    165. Herrinton LJ, Friedman GD. Serum cholesterol concentration and risk of brain cancer. BMJ. 1995 Feb 11; 310(6976):367-8. PMID: 7866214.
      View in: PubMed
    166. Herrinton LJ, Stanford JL, Schwartz SM, Weiss NS. Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst. 1994 Sep 07; 86(17):1336-9. PMID: 8064892.
      View in: PubMed
    167. Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control. 1994 Sep; 5(5):479-83. PMID: 7999970.
      View in: PubMed
    168. Herrinton LJ, Weiss NS, Koepsell TD, Daling JR, Taylor JW, Lyon JL, Swanson GM, Greenberg RS. Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health. 1994 Jul; 84(7):1142-4. PMID: 8017540.
      View in: PubMed
    169. Herrinton LJ, Weiss NS. Incidence of Waldenström's macroglobulinemia. Blood. 1993 Nov 15; 82(10):3148-50. PMID: 8219203.
      View in: PubMed
    170. Herrinton LJ, Saftlas AF, Stanford JL, Brinton LA, Wolfe JN. Do alcohol intake and mammographic densities interact in regard to the risk of breast cancer? Cancer. 1993 May 15; 71(10):3029-35. PMID: 8490831.
      View in: PubMed
    171. Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol. 1993 May; 3(3):308-18. PMID: 8275205.
      View in: PubMed
    172. Herrinton LJ, Demers PA, Koepsell TD, Weiss NS, Daling JR, Taylor JW, Lyon JL, Swanson GM, Greenberg RS. Epidemiology of the M-component immunoglobulin types of multiple myeloma. Cancer Causes Control. 1993 Mar; 4(2):83-92. PMID: 8481497.
      View in: PubMed
    173. Herrinton LJ, Koepsell TD, Weiss NS. Smoking and multiple myeloma. Cancer Causes Control. 1992 Jul; 3(4):391-2. PMID: 1617129.
      View in: PubMed
    Herrinton's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.